Laden…
Methylphenidate is a central nervous system stimulant that primarily acts by inhibiting the reuptake of dopamine and norepinephrine. It is medically used for the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy. The substance increases the concentration of these neurotransmitters in the synaptic cleft, leading to increased alertness and concentration ability. Side effects may include cardiovascular strain and potential for dependence.
Class
Stimulants
Pharmacological context
Mechanism
Methylphenidate primarily acts as an inhibitor of the dopamine and...
Short read on known pharmacology
Interactions
No curated pairs visible
Curated visible combinations
Risk theme
Interpret risks carefully
Condensed from structured notes
Receptor Targets
Mechanism of Action
Designations
IUPAC: Methylphenidat
Legal Status
Legal status not verified by official sources. Please check current legislation independently.
Information without guarantee. Not legal advice.
Synapedia Evidence
Methylphenidate primarily acts as an inhibitor of the dopamine and norepinephrine transporter, leading to increased availability of these neurotransmitters in the synaptic cleft. This results in enhanced stimulation of the central nervous system.
Known Effects
Individual effects may vary significantly. These are pharmacologically documented effects.
Reported range 10–20 mg
Total duration 3–6 hours
Oral
| Tier | Dosage |
|---|---|
| Light | 5–10 mg |
| Reported | 10–20 mg |
| Strong | 20–40 mg |
Oral
Onset
30–60 minutes
Peak
1–3 hours
Total duration
3–6 hours
After effects
2–4 hours
Avoid uncertain dosage claims and do not infer numbers when data is unclear.
Dose sensitivity varies greatly between individuals. Body weight, tolerance, route of administration, combinations, and pre-existing conditions significantly affect outcomes. These figures are not dosing recommendations — they describe reported ranges, not safe amounts.
Risks
Overdose Risk
Kardiovaskuläre Komplikationen (Hypertension, Tachyarrhythmie) und Krampfanfälle dominieren. Keine spezifische Antidottherapie. Symptomatische Behandlung: Benzodiazepine gegen Krampfanfälle, Vasodilatatoren bei Hypertension.
Safer Use
The risks listed may be incomplete. Especially for research chemicals and rare substances, available data is limited.
Interaction details from the knowledge layer are still being translated.
Interaction data is based on known mechanisms. Unknown or rare interactions are possible and may be life-threatening.
Based on substance class, receptors, mechanisms, and effect profile.
This information is for scientific and harm-reduction purposes only. It does not constitute medical advice.
Share a report, observation, or question about this substance. Entries are reviewed before publication and marked as unverified community signals.
These entries are submitted by users and are not verified. They may contain subjective experiences, observations, source leads, or corrections. They do not replace scientific data and are not consumption advice.
The signal hub collects approved risk signals, experience reports and source leads by relevance.